GLP-1 5,9, , pH =5,9, GLP-1
Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited
Conversely, we found little evidence that GLP-1RAs may cause or exacerbate cognitive impairment, which is of importance to patients who may need to take these medications for their currently licensed (and expanding) indications
This systemic reach has led researchers to explore whether lower, sustained doses of GLP-1 RAs could maintain receptor activity sufficient to preserve metabolic and organ health without the adverse events often seen with aggressive dosing
Skipping meals or snacking randomly can lead to fatigue, muscle loss, digestive discomfort, and vitamin deficiencies
Others report emotional flatness, reduced motivation, or a blunted sense of reward, particularly around food